Ontonix Forms Part of AFFIRMO Project Consortium

/

Como, 24-th October, 2020. Ontonix, a technology company delivering Quantitative Complexity Management (QCM) hardware and software (HW & SW) for early warnings and anomaly detection, participates in the AFFIRMO project, funded by the EU in the Horizon 2020 Framework.

The specific aim of the AFFIRMO project (Atrial Fibrilation integrated approach in Frail, multimoRbid and polyMedicated Older people) is to implement and test the effectiveness of an integrated patient-centered holistic care pathway for the management of older patients with Atrial Fibrillation and multimorbidity, which will facilitate cooperation among different health disciplines and promote a shared decision-making process. The final result will be to provide comprehensive management of AF, which being tailored in the context of coexisting disease and patient preferences can potentially lead to a reduction in physical and mental impairment allowing the older patient to cope better with multimorbidity.

The Consortium comprises the following partners:

Universita degli Studi di Padova (IT)
the University of Liverpool (UK)
Universiteit Gent (BE)
Karolinska Institutet (SE)
National University of Ireland Maynooth (IE)
Consiglio Nazionale delle Ricerche (IT)
Stichting Rijnstate Ziekenhuis (NL)
Universitatea de Medicina si Farmacie'Carol Davila' din Bucuresti (RO)
Aalborg Universitet (DK)
Faculty of Medicine, University of Belgrade (RS)
Moverim Consulting sprl (BE)
Advice Pharma Group srl (IT)
Ontonix (IT)
Arrhythmia Alliance (UK)
European Union Geriatric Medicine Society aisbl (BE)
Multimedica spa (IT)
Universita Cattolica del Sacro Cuore (IT)
Heart Care Foundation Onlus (IT)

The participation of Ontonix will focus on contributing to a novel stratification instrument to define subgroups of multimorbid patients in need of specific or bespoke approaches to integrated care (i.e., more oriented to social or medical or rehabilitation aspects). This will be central to developing and validating a patient-centred, stratified care pathway, providing a tailored management programme based on different disease clusters and severity.

In addition, Ontonix will focus on identifying key quality performance indicators (QPIs) that will express the burden of multimorbidity. These key QPIs will be used to plan and monitor the effectiveness of interventions developed to improve AF and multimorbidity management and can potentially be integrated into the CGA (Comprehensive Geriatric Assessment).

The AFFIRMO project (899871) has a duration of five years.

For more information on Ontonix, visit www.ontonix.com/

/ /

Dr. Jacek Marczyk

Visionary, ex rocket scientist, businessman and writer with over 35 years of experience in QUANTITATIVE large-scale Uncertainty and Complexity Management in diverse fields (manufacturing, finance, economics).

Author of ten books on simulation, uncertainty and complexity management, rating.

Developed in mid 90s the theory of eigenvalue orbits, a generalization of the concept of eigenvalue.

In 2000-2005 has developed the first Quantitative Complexity Theory (QCT), including a comprehensive measure of complexity.

Founded Ontonix Complexity Management in 2005 in the USA and launched in 2006 the first commercial system for MEASURING and managing complexity: OntoSpace.

www.ontonix.com

In 2009 developed real-time technology to measure the complexity and stability of patients during operation or permanence in Intensive Care Units.

http://www.ontomed.net

Developed a new theory of risk and rating published in 2009 in a book entitled "A New Theory of Risk and Rating".

Over last decade develops quantitative complexity management (QCM) technology and solutions for applications in economics, finance, Risk Rating and Management as well as in Asset Management and medicine. In the past five years works towards the democratization of ratings.